Five Prime Therapeutics (FPRX) Says Glaxo (GSK) Exercised Right to Take Exclusive License of Proprietary Protein Discovery Platform
Tweet Send to a Friend
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that GlaxoSmithKline (NYSE: GSK) exercised its option to take an exclusive license to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
